Blackstone signs deal to buy Piramal Glass

It is now officially confirmed that after a major race where also Bain Capital were involved, finally private equity major Blackstone has won the deal to acquire Piramal Group’s Piramal Glass for around $1 billion.

The deal includes an upfront payment of $850 million while Piramal Group will get approximately $150 million on achieving certain milestones, to be paid over 2 years.

Piramal Group had completed another billion dollar deal, when they had sold US-based DRG for around a billion dollars. Bloomberg Quint can be cited that In June, the group agreed to sell a 20% stake in its Piramal Pharma Ltd. arm to private equity firm Carlyle Group Inc. for $490 million, giving the business an enterprise value of $2.7 billion.


About Piramal:

Piramal Glass is a global specialist in design, production, and decoration of premium glass packaging. They are the largest specialty glass player in Asia and have been the fastest growing glass packaging company in the world for more than a decade. They are one of the only significant players from Asia with a very significant presence in the premium glass-packaging segment. Piramal Glass has a daily production of 1,475 tons of container glass packaging per day in its different facilities spread over India, Sri Lanka and the USA and also operates facilities for decoration.

We have four manufacturing facilities; one in the USA, one in Sri Lanka, and two in India with an overall capacity of 1475 tonnes per day (TPD) with 12 furnaces and 65 production lines. We also design, produce and decorate specialized glass packaging for the global cosmetics, perfumery, skin-care, food, and beverage industry.

Kosamba, India

At Kosamba, India facility, we produce USP Type I, II, and III glass Bottles and Vials for the pharmaceutical industry, Type III glass bottles for Cosmetics & Perfumery industry, and also Feeder-Coloured bottles in various shades. Here we have a dedicated facility for Type-I borosilicate glass for moulded pharmaceutical glass packaging and a dedicated facility for premium Cosmetics & Perfumery glass bottles. Our in-house Decoration Unit, ANSA Deco Glass, is also present at this location.

Jambusar, India

At Jambusar, India facility, we have one of the world’s largest single installed capacities for pharmaceutical packaging in amber-glass. In this facility, we produce Type III amber-glass bottles and vials pharmaceutical industry. And Type III flint bottles for the Pharmaceutical, Cosmetics & Perfumery, and Specialty Food & Beverage industry.

Park Hills, USA

At Park Hills, USA facility, we produce Type III flint bottles, for the Cosmetics & Perfumery and Specialty Food & Beverage industry. There is an infrastructure to produce Feeder-Coloured bottles in various shades. All lines have inspection machines and hot and cold end coating facilities. We have in-house mould design and manufacturing workshop. The glass bottle decoration facility is located at Williamstown, New Jersey.

Horana, Sri Lanka

At Horana, Sri Lanka facility, we produce Type III flint and amber glass bottles for the Pharmaceutical, Cosmetics & Perfumery, and Specialty Food & Beverage industry. There is an infrastructure to produce Feeder-Coloured bottles in various shades and a dedicated in-house glass bottle printing facility in this facility.

11.12.2020, Piramal Group / Blackstone

此网站新闻材料的版权属于公司或第三方的新闻提供者,其所有权利保留。所有新闻材料对其访问者只能限于其本人使用,并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供,当应用此新闻材料时,每个使用者都同意遵守,并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.